Study: Yaz Has Higher Risks of Blood Clots

A new study of 1.3 million Danish women over nine years adds to the evidence that some newer birth-control pills, including the best-seller Yaz, have a higher risk of causing potentially dangerous blood clots. Newer pills containing drospirenone, a synthetic hormone, were linked to a six-fold increase in the risk of venous thromboembolism, which is the formation of clots in the lower leg or thigh that can break loose and travel to the lungs. That risk was compared with a three-fold increase in women using older contraceptives containing the synthetic hormone levonorgestrel. The studywas published Tuesday on the Web site of BMJ, formerly known as the British Medical Journal. A BMJ editorial added, “It is crucial, however, not to exaggerate...

Read more »

Just How Safe is Yaz? Women Need to Know!

The oral contraceptive Yasmin was released in 2001 by the pharmaceutical company Bayer, followed byYaz in 2006. They differ from other birth control pills in the synthetic progesterone they utilize, drospirenone, which is marketed as less likely to cause weight gain and bloating than other birth control pills. Yaz soon became the most popular birth control pill in the U.S., due in part to a widespread advertising campaign promoting the drug as what theNew York Times dubbed “a quality of life treatment,” claiming it could also clear up acne, prevent bloating and ease the depression and anxiety associated with both PMS and the controversial condition of PMDD. It prevents pregnancy at the same rate of...

Read more »

Yaz® Drug Injury Lawyer

The Yaz® birth control pill has been on the market since 2006. Yaz is taken orally once daily to prevent pregnancy. Yaz differs from other birth control methods because it contains a progestin hormone called drospirenone, which can increase potassium levels in the bloodstream. Yasmin®, a birth control drug very similar to Yaz, has been on the market since 2001. It contains the same hormone as Yaz and is associated with the same health issues. Ocella® is sometimes supplied by pharmacies instead of Yaz or Yasmin, and carries the same risks. Dangerous Side Effects Yaz has been linked with serious adverse heart problems in women taking the drug. In a reprimanding letter sent to the manufacturer of Yaz, the Food and Drug Administration (FDA) warns of blood clots, heart attack, stroke, and...

Read more »

How We Can Help

If you or a loved one has suffered serious injury including blood clots, deep vein thrombosis, pulmonary embolism, stroke, organ failure or death after taking Yaz, Yasmin, Ocella, Zarah or Gianvi you may be entitled to compensation.  An experienced pharmaceutical attorney can help evaluate your claim and give you the advice you need to go forward with your case. The Yaz / Yasmin attorneys at Jackson Allen Williams, LLP are familiar with birth control side effects litigation and can help you understand your rights.  Our Yaz/Yasmin/Ocella/Zarah/Gianvi litigation team is already representing women throughout the United States who have suffered serious side effects from Yaz, Yasmin, Ocella, Zarah or Gianvi.  If you would like to speak with a Yaz lawyer about your legal...

Read more »

IndiYaz A Jones Cartoon Teaches Sales Reps About Their Drug

At Bayer, company executives have released a series of Saturday-morning-style cartoons which they hope will motivate their sales reps to continue marketing their birth control drugs. The most popular of these cartoons is “IndiYaz A Jones and the Temple of Estradiol.” According to Pharmalot.com, estradiol is a hormone that is contained in the Yaz contraceptive which is sold by Bayer. The cartoons were created by an animator at Bayer in 2008, and were only meant for internal training purposes. They contain a variety of different pitches that can be imitated and articulated by the sales representatives at Bayer. The cheap cartoons contain dialogue about the drug in a staged format, as if IndiYaz A Jones himself is searching for...

Read more »

Current Yasmin and Yaz Label Warnings Are Inadequate

Seated around a U-shaped configuration of tables sat the 26 member FDA Advisory Committee — all scientists or physicians gathered to discuss the risks of birth control pills containing DRSP. They focused on the risks as described in recent studies, including the FDA’s own study that looked at over 800,000 women during a six year time period. The results of the FDA study concluded that new users of Yasmin may be twice as likely to experience a blood clot as users of other birth control pills containing the progestin Levonorgestrel. During the first two hours of the hearing, an FDA representative presented an overview of the studies Bayer conducted after Yasmin was introduced to the market. The Bayer studies suggested that Yaz...

Read more »

Pfizer Recalls One Million Packs of Birth Control Pills

On January 31, 2012, the FDA posted a safety recall of one million packs of oral contraceptive pills because the pills may not be effective in preventing pregnancy. The recall covers Pfizer birth control Lo/Ovral-28 and generic versions of the drug (Norgestrel and Ethinyl Estradiol) with expiration dates between July 2013 and March 2014. Recalled pills may be labeled under theAkrimax Pharmaceuticals brand. Exact lot numbers for the recalled products are available on the FDA Safety Recall website. According to Pfizer, the problem was caused by both mechanical and visual inspection failures on the packaging line which caused pills to be packaged out of order. Generally, birth control packets contain three weeks of contraceptive...

Read more »

Yaz Trial Delayed

he first Yasmin/Yaz trial involving a woman who suffered a pulmonary embolism after taking the birth control pill scheduled to begin next week has been delayed by Judge Herndon, the federal judge presiding over thousands of lawsuits. In an order issued December 31, Judge Herndon indefinitely continued the start of that case and ordered the parties to meet with a special mediator in an attempt to negotiate a settlement for the litigation. Judge Herndon determined that the best interests of the litigation will be better served by delaying the start of the bellwether trial, which was designed to help the parties gauge how juries are likely to respond to evidence that will be presented in many of the cases. He appointed ProfessorStephen...

Read more »

"Yaz, Yasmin and Ocella Birth Control Drugs may have Serious Side Effects

Yaz/Yasmin/Ocella Birth Control Side Effects Lawsuits Yaz, Yasmin, Ocella Lawsuits, Side Effects: Gallbladder Damage, Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Blood Clots, Heart Attacks, Strokes, Death Yaz, Yasmin and Ocella Birth Control Drugs may have Serious Side Effects Yaz, Yasmin and Ocella Birth Control Drugs September 26,2011: The U.S. Food & Drug Administration (FDA) issued an updated Drug Safety Communication informing the public that it "remains concerned about the potential increased risk of blood clots with the use of drospirenone-containing birth control pills." The FDA is advising patients to speak to their healthcare professional about the risk of blood clots before deciding which birth-control...

Read more »